Pharmaceutical Technology Europe-03-01-2007

Biopharmaceuticals
Pharmaceutical Technology Europe

March 01, 2007

Disposables simplify the flow of people and materials through a facility, decreasing both its footprint and amount of equipment needed, as well as minimizing upfront capital costs.

Pharmaceutical Technology Europe

Large stability studies for drug products and devices with multiple strengths, packaging configurations and orientations can cost millions of dollars for the analytical testing alone.

Pharmaceutical Technology Europe
Manufacturing & Processing

March 01, 2007

The increasing demand for speed-to-market requires that modern pharmaceutical laboratories work faster, more accurately and efficiently than before. Unavoidably, this leads to a number of bottlenecks that threaten the overall laboratory operation and efficiency.

Pharmaceutical Technology Europe
Manufacturing & Processing

March 01, 2007

The acquisition and integration of postdevelopment phase staff could be likened to a relay race where making the hand-over of the baton correctly is critical.

Pharmaceutical Technology Europe
Outsourcing

March 01, 2007

While the Gulf region has already become well-known for its globally accepted infrastructure, and large projects in tourism and other service areas, major investments in healthcare or pharmaceuticals have failed to develop as well.

Manufacturing & Processing
Pharmaceutical Technology Europe

March 01, 2007

Pharmaceutical Technology Europe
Outsourcing

March 01, 2007

Finding a CMO partner will take time and an incorrect choice that leads to changing the CMO is financially very painful.

Pharmaceutical Technology Europe

While single-use technologies can be used for filtration, storage and at connection points in egg-based vaccine production, their use multiplies in cell-based applications.

Pharmaceutical Technology Europe

Although the CRO may not wish to draw attention to weaknesses in the intended trial, failing to do so is a great disservice.